Ahmedabad: With Gujarat recording the first case of Omicron on Saturday and the cases of Covid variants operating from four on Saturday to 21 on Sunday night, vital questions are: What are the chances of re-infection? Dr.
Mukesh Maheshwari, a pathologist based in the city, said that the vaccination drive has shown its impact with new cases and deaths dropped significantly when a vaccinated population increased in the state.
“Acquiring antibodies from Wane vaccinations after some time, but there was no linear increase in the case,” he said.
“Low cases and mortality showed cell immunity T.” Dr.
Bhavini Shah, Director of the Pathology Lab Chain, said that their studies earlier this year in medical professionals have shown that around 30% of the samples have reduced the level of antibodies after three months.
“With the emergence of a new variant, more citizens come for antibody tests.
Even though it is definitely a factor to ensure the projection of infection in the future, it is not the only factor,” he said.
“It takes time to understand the new variant.” But does that mean a re-infection? To answer it, some empirical data will be needed, experts said.
With a high number of vaccinations – 93% get the first JAD and 73% get a second shot – and a large population test positively on sero surveys in a row, other factors also play.
Experts have urged residents not to let their guards down.
Meanwhile, IIPH, Gandhinagar, (IIPH-G) has moved proposals to the center to conduct research in the immunity of cells.
Prof.
Dileep Mavankar, Director of IIPH-G, said that it is important to understand the role of long-term immunity along with antibodies produced by vaccination.
“We propose to increase the existing BSL-2 laboratory to BSL-3 and train the virologists and lab staff to work on the infectious virus,” he said.
“BSL-3 Labs are designed to load the risk of the spread of aerosols for personnel working in the lab and outside.
Apart from Covid-19, such labs will be useful for nipah, very pathogenic influenza viruses, etc.” Mavalankar said that understanding immunity will be be the key to fighting a future pandemic.
Two response CD4 + and CD8 + special antigens will be measured by experts in patients who have recovered and in vaccinated people.
Samples will also check the impact on the cytokine (IL-2, IFN-G and TNF-A) in patients.